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The gut microbiome affects many aspects of human health including response to 
cancer treatments. A healthy gut microbiota serves important functions in maintaining the 
gut barrier’s structural integrity and enhance responses to certain cancer treatments. Recent 
work has demonstrated that certain gut bacteria can modulate the host response to immune 
checkpoint inhibitors (ICIs), and, in mice, response to ICIs can be increased by increasing 
the abundance of probiotics like Akkermansia muciniphila, or Lactobacillus acidophilus. 
Diet-based interventions hold promise for translating microbiome modification into a 
clinical setting; however, progress has unfortunately been slowed by a lack of evidence 
regarding how specific food products can affect microbes, particularly in complex 
communities such as the gut microbiome. Increasing the abundance of probiotics thus 
represents a promising approach to modulate the likelihood of response to ICIs in humans. 
As such, it is important to investigate how certain important bacterial species can be 
enriched in gut microbiota via the use of polyphenol-rich fruits. The objective of this 
project focuses on the use of a novel in vitro human colonic model to simulate a colon 
environment without the interference from the host, to study the interaction between gut 
microbes from study participants of a lung cancer prevention trial and polyphenol-rich 
black raspberry (BRB) extract; and to characterize the microbial metabolites. After 
analyzing representative HCM samples using Liquid-chromatography Mass spectrometry 
(LC/MS) and statistical analysis, all three sections of the colon had shown distinct 
metabolic profiles for endogenous polar metabolites during BRB treatment compared to 
pre-treatment; two phenolic compounds were statistically significant in ascending and 
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transverse colon when compared between treatment phase versus post-treatment phase. 
Meanwhile, six short-chain fatty acids (SCFAs) were detected with statistical significance 
in ascending colon, and two SCFAs were detected with statistical significance in 
descending colon during the BRB treatment. In summary, this study indicated that BRB 
extract is capable of remodeling gut microbial metabolism and alter the levels of many 
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There are thousands of different types of microbes living in and outside of the 
human body. Out of many habitats, one particularly important place where trillions of 
microbes exist in the human gut, which houses many microbes in its mucous membrane 
and could take up 1-3% of our weight. In a healthy human, most bacteria can be divided 
into five phyla (Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, 
and Verrucomicrobia) and with a majority of them being commensal bacteria [1]. Many 
studies involving animal models and clinical analysis had shown that these microbes play 
an important role in regulating homeostasis, metabolic processes and preventing gut 
inflammations, thus, creating a symbiosis relationship [2]. It is well-known that the delicate 
balance of microbiota in the gut is involved in maintaining gut integrity, and gut microbiota 
can be influenced by individual diets [3][4]. When the gut barrier is compromised, it 
provides an opportunity for pathogenic invasion. Thus, altering the delicate microbiome 
balance contributes to the inflammatory response [5]. As diet is believed to be a major 
factor in influencing this microbial modulated immune response, fluctuations in nutrient 
intake may instigate a vicious cycle, eventually leading to inflammatory bowel disease 
(IBD) such as ulcerative colitis, where ulcers form in the colon. This is a well-known 
precursor to colorectal cancer formation [6].  
In addition, recent work has demonstrated that certain gut bacteria modulate 
response to immune checkpoint inhibitors (ICIs), and, in mice, response to ICIs can be 
increased by increasing the abundance of probiotics such as Akkermansia mucinphilia 
[7][8]. Diet-based interventions hold promise for translating microbiome modification into 
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a clinical setting; however, progress has unfortunately been slowed due to a lack of 
evidence regarding the ways in which specific food products can affect microbes, 
particularly in complex communities such as the gut. Increasing the abundance of 
probiotics via nutritional intervention thus represents a promising approach to modulate 
the likelihood of response to ICIs in humans. As such, it is important to maintain a healthy 
gut microbiota and correct any dysbiosis as it serves important functions in maintaining 
the gut barrier’s structural integrity and enhance responses to certain cancer treatments 
[9][10].  
In recent years, there are numerous attempts in the scientific community to 
characterize how specifically can diet influence microbial diversity and how such change 
can influence human health. Fruit rich in polyphenol have captured much attention as 
polyphenol has antimicrobial, anti-cancer and anti-inflammatory properties [11]. Like 
many other berries, such as strawberry and pomegranate, black raspberry (BRB) contains 
a rich source of phenolic compounds like anthocyanins, ellagitannins or quercetin [12].  In 
an animal study done on F344 rats, ellagic acid, a phenolic acid found in BRB, can prevent 
carcinogenic transformation [13]. Other compounds, such as β-sitosterol or ferulic acid, 
were able to curb premalignant and malignant formation for various forms of aerodigestive 
cancers [14][15]. Polyphenols can be dived into flavonoids or non- flavonoids and BRB 
contains both groups [16].  It is also reported that fruits rich in polyphenols can promote 
the growth of probiotics, restore dysbiosis, regulate host body weight and thus improve the 
host’s overall health [17][18][19].  Many of these studies were done in animal models or 
healthy volunteers, which has important scientific significance with a real-life simulation 
of how diet, microbiota and host will interact. Yet, the limitation of such studies includes 
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restriction in the frequency of sample collection, unable to control all parameters involved 
and unable to establish a clear link of how diet and microbiota interact. All these limitations, 
however, can be overcome by the use of in vitro models such as the Human Colonic Model 
(HCM) established in our lab. Therefore, in our study, we plan to utilize a short-term (2-
weeks) intervention study in HCM to simulate the growth environment for gut microbes 
while removing host responses to specifically focus on the interaction between polyphenol 
and gut microbiota from participants of a lung cancer prevention trial.  
We hypothesize that the dietary intervention of BRB will remodel gut microbial 
metabolism and alter the production of potentially beneficial/anti-inflammatory 
metabolites. The short-term goal of our project aims to uncover how black raspberry extract 
can influence human gut microbial metabolism and how these metabolites could modulate 
host health in cancer prevention. In the long run, we aim to elucidate the mechanism of the 
interplay among dietary intervention, gut microbiota and microbial metabolism and cancer, 
so that eventually, we can apply the knowledge in the clinical setting of cancer 
prevent/treatment.  
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Materials and Methods 
Chemicals 
HPLC-MS-grade acetonitrile, ammonium acetate, formic acid, and acetic acid were 
purchased from Fisher Scientific (Pittsburgh, PA, USA). Phenolic compound standards 
including protocatechuic acid, 3,4-Dihydroxyphenyl ethanol, 3,4-dihydroxyphenylacetic 
acid, gallic acid, caffeic acid, isoferulic acid, urolithin A, transresveratrol, equol, daidzein, 
homovanillic acid sulfate, genistein, naringenin, phloretin, kaempferol, epicatechin, 
catechin, enterolactone, quercetin, hesperetin, epigallocatechin, isorhamnetin, myricetin, 
chlorogenic acid, roseoflavin, phlorizin, epicatechin gallate, epigallocatechin gallate, 
quercetin 3-D-galacoside, and rutin were purchased from Cayman company (Ann Arbor, 
MI, USA). 10mM volatile free acid mix, including acetic acid, propionic acid, isobutyric 
acid, butyric acid, isovaleric acid, valeric acid, hexanoic acid, isocaproic acid, n-heptanoic 
acid and 2-methylbutyric acid were purchased from Sigma–Aldrich (St. Louis, MO, USA). 
13C4-sodium butyrate was purchased from Avanti polar lipids, Inc. (Alabaster, AL, 
USA). Pyridine, N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC·HCl) and 3-
Nitrophenylhydrazine hydrochloride (3NPH·HCl) were also purchased from Sigma-
Aldrich. 
Human Colon Microbiota 
 Fresh fecal samples were obtained from two study participants of a lung cancer 
prevention trial. Approval was obtained from the Institute Review Board (IRB) committee 
of the Ohio State University before the study (clinical trial approval number 
NCT04267874), and informed consent was obtained from the fecal donors. 
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Microbiome Extraction 
 Microbiome from study participants of a lung cancer prevention trial was obtained 
using fresh stool sample by mixing with phosphate-buffered saline and vortex. 1 ml of the 
resultant solution was added to 9ml of Gifu Anaerobic Broth (GAM, HIMEDIA) and 
cultured overnight [20]. All above process was done in the anaerobic chamber to preserve 
obligate anaerobes (Coy Lab, Grass Lake, MI, USA). 3 ml of the microbiome culture was 
added into each vessel representing different sections of the colon.  
Human Colonic Model Set-up 
  
The Human Colonic Model (HCM) was set up using consist of three bioreactors to 
simulate segments of the large intestine in humans (Figure 1). Vessel 1, 2 and 3 represent 
 
Figure 1. A schematic of Human Colonic Model (HCM), which consist of three pH and 
temperature controlled bioreactors to represent three segments of the large intestine, feeding 
bottle representing food content from small intestine (medium pre-treated with stomach 
enzyme and incubated for 2 hours to mimic the digestion, two bottles containing acid and 
base respectively to control the pH and a waste vessel to represent excretion. 
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the ascending, transverse and descending colons, respectively. Vessels contain various 
volumes of medium respectively as we described earlier [21]. The vessels were maintained 
at 37 °C by a water bath to simulate body temperature while the anaerobic environment 
was maintained by constant N2 gas flushed through the entire system. Also, 3 ml of the 
recovered gut bacteria were inoculated into each vessel. 100 ml of medium was transferred 
three times a day with automated pumps controlled by in-house software and electric 
controllers to simulate human food consumption. The HCM model had run for a total of 6 
weeks, weeks 1-2 as equilibrium phase, weeks 3-4 for treatment followed by 2 weeks post-
treatment. The system was monitored with daily plate culture as described below.  
HCM Feeding Medium 
 The feeding medium was prepared using the in-lab protocol. Briefly, 59.5g of  Gifu 
Anaerobic Broth (GAM, HIMEDIA) was added to 4L of distilled water, hydrochloric acid 
was added to adjust to pH 2. The mixture was autoclaved for 30 minutes then cooled to 
37 ̊C and shake in an incubator for an hour. 2.4g/L of bile salt and 0.4g/L pancreatin were 
added to the mixture inside the biosafety hood, sodium hydroxide was added to bring pH 
to 5.5. The mixture was shaken in an incubator for 2 hours at 37 ̊C. For black raspberry 
treated media, 5ml/L of concentrated black raspberry extract supplement (Berri Product 
LLC) was added to the mixture.  
Daily Culture Plate 
 Daily culture plating was performed to monitor the overall microbial growth in the 
HCM system and ensure the stability of the HCM. 1 ml of liquid extracted from each vessel 
every day and the sample was brought into the anaerobic chamber for culture. Samples 
from three vessels undergo 6 fold serial dilution before culture on a Gifu Anaerobic Broth 
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agar plate. The agar plate was left in a 37 ̊C incubator for 24 hours and the colonies were 
counted. Additional samples were collected and stored in -80 ̊C at the same time for 
additional metabolite and genomic analysis. 
Sample Preparation and Liquid-Chromatography Mass Spectrometry (LC/MS)  
All liquid chromatography-mass spectrometry (LC/MS) related experiments were 
performed on a Vanquish UHPLC system coupled with a hybrid Quadrupole Orbitrap Q 
ExactiveTM mass spectrometer system (Thermo Electronics, Waltham, MA). Briefly, the 
UHPLC system has a temperature-controlled autosampler for high-throughput analysis, a 
column compartment and a binary pump for separation of analytes, the hybrid Quadrupole 
Orbitrap Q ExactiveTM mass spectrometer can achieve high-resolution analysis (up to 
140,000) for accurate m/z measurement and therefore enable confident compound 
identification.  
Polar Metabolite Extraction 
Both intracellular and extracellular polar metabolites extraction were performed 
[20]. Briefly, 800 μl of thawed HCM samples were centrifuged at 1400 rpm for 10 minutes, 
supernatants were transferred to sterile Eppendorf tubes. For extracellular metabolite 
extraction, 100 μl of the supernatants were transferred to new sterile Eppendorf tubes and 
250 μl of methanol was added to each tubes containing supernatants. For intracellular 
extraction, the pellets from the first round of centrifugation were washed with 500 μl PBS 
and centrifuged again at 14000 rpm for 10 minutes, supernatant from the tube was removed 
and the whole process was repeated three times, then 250 μl of methanol was added to the 
pellets. The above step was performed on the supernatant containing exogenous 
metabolites too. The following steps described below were performed on both endogenous 
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and exogenous samples. The samples were vortex for 2 minutes before they were put in -
20 ̊C for 20 minutes. Then, the samples were centrifuged again at 14000 rpm for 20 minutes, 
and the resultant supernatants were transferred to a clean LC valve for analysis. The 
samples were tested twice in both positive and negative mode. Each time, 10 μl aliquot was 
injected into the HPLC-MS/MS instrument for analysis using Xbridge BEH Amide (2.5um, 
2.1x150mm, Waters, Milford, MA, USA) at 0.350 ml/min using mobile phase A ( 5 mM 
ammonium acetate in 10% acetonitrile/ 90% water and 0.2% acetic acid), mobile phase B 
( 5 mM ammonium acetate in 10% acetonitrile/ 90% water and 0.2% acetic acid).  
Phenolic Metabolite Extraction 
Samples were prepared using a protocol established by a previous study [22], 150 
μl of HCM samples were dissolved in 1.5 ml of 80% methanol. The samples were sonicated 
for half an hour at room temperature and centrifugation at 1000G for 10 minutes at 4 ̊C. 
The supernatant collected using a 0.2 μm PTFE filter. 500 μl was transferred to a clean LC 
valve and loaded onto the instrument. The samples were tested twice in both positive and 
negative mode. Each time,  10 μl aliquot was injected into the HPLC-MS/MS instrument 
for analysis using XTERRA RP 18 (3.5um, 3.9x100mm, Waters, Milford, MA,USA) at 
0.300 ml/min using mobile phase A (89.9% water/ 10% acetonitrile/0.1% formic acid), 
mobile phase B (69.9% water/ 30% acetonitrile/ 0.1% formic acid).  
Short-Chain Fatty Acid Extraction 
Samples were prepared using methods described by Chen et al [23]. A range of 
short-chain fatty acids (SCFA) standards were prepared using 10mM volatile free acid 
mix (Sigma–Aldrich, St. Louis, MO, USA) as described in Table 1: 
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Table 1: table showing standard preparation of SCFA from 10mM acid mix for the 
calibration curve 
Dilution factor acid mix/ μl 2-methyl 
butyric acid/ μl 
50% 
acetonitrile/ μl 
2.5x 80.00 80.00 40.00 
5.0x 40.00 40.00 120.00 
7.5x 26.67 26.67 146.66 
10.0x 20.00 20.00 160.00 
 
 
After which, 20 μl of each 1mM 13C4 sodium butyrate, 200mM 3-nitrophenylhydrazine 
hydrochloride solution and 120 mM M-(3-dimethylaminopropyl)-N’-ethylcabodilmide-6% 
pyridine solution were added to the standards respectively. The standards above were then 
diluted by 10 times, 100 times and 1000 times and result in 16 samples in total, serving as 
a calibration curve to quantify the amount of SCFA present in the HCM samples. The 
concentration of SCFAs was calculated and the peak area was used to draw a calibration 
curve to quantify the amount of SCFAs present in HCM samples.  
For HCM samples, 1 ml were transferred into a fresh Eppendorf tube and centrifuge 
for 10 minutes at 14000 rpm. 20 μl of the supernatant was transferred to a new Eppendorf 
tube, 20 μl of each 1mM 13C4 sodium butyrate, 200mM 3-nitrophenylhydrazine 
hydrochloride solution and 120 mM M-(3-dimethylaminopropyl)-N’-ethylcabodilmide-6% 
pyridine solution was added to the samples respectively. Both standard and HCM samples 
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were vortex before putting into a 40 ̊C water bath for half an hour. Then, they were cooled 
on ice for 1 minute and diluted with 1.92 ml of 10% aqueous acetonitrile. The prepared 
samples were then diluted 20 times to fit the range of the standards, 500 μl was transferred 
to a glass valve and loaded onto the instrument. Vanquish UHPLC System (ThermoFisher, 
Waltham, MA, USA) was used for metabolites analysis, 10 μl aliquot was injected into the 
HPLC-MS/MS instrument for analysis using Acquity UPLC CSH C18 Column (1.7um, 
2.1x100mm, Water, Milford, MA, USA) at 0.500 ml/min using mobile phase A (100% 
water/ 0.01% formic acid) and mobile phase B (100% Acetonitrile/ 0.01% formic acid).   
Statistical analysis 
 The SCFA spectral data generated by HPLC-MS/MS instrument containing both 
standard and HCM samples were manually processed using the Quanbrowser module of 
Xcalibur 4.0, to be converted into relative abundance in Microsoft Excel. Peak area data 
were filtered if coefficient variant (CV) is below 0.25 from QC and normalized with 
bacterial plate count from daily HCM plating.  The relative abundance of each SCFA 
( acetic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, valeric acid, 
hexanoic acid, isocaproic acid, n-heptanoic acid and 2-methylbutyric acid) was calculated 
using a calibration curve established from standards prepared. For polar metabolites, the 
raw data from LC/MS was processed using Compound Discover 3.1 and were filtered (CV 
< 0.25) and normalized before it was imported to MetaboAnalyst for further analysis. 
PLSDA plots and VIP score plots were generated to show the differences in the relationship 
between the pre-treatment and treatment phase. The above process was repeated for the 
processing of phenolic compounds.  
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Results 
In this thesis study, we aim to uncover how a representative dietary component, 
black raspberry, can influence human gut microbial composition and metabolism, so we 
can eventually understand its gut microbiota-mediated health effects on humans. We 
hypothesize that the addition of BRB as a dietary intervention will remodel microbial 
metabolism and alter the production of potentially beneficial metabolites such as straight-
chain short-chain fatty acids (SCFAs). The HCM contains three vessels representing 
ascending, transverse and descending colons, each vessel has temperature and pH sensors 
for environmental control and auto-pumps for feeding delivery at fixed time intervals. The 
HCM was run for 6 weeks to observe the longitudinal change in microbiota and metabolites 
produced when BRB was added as treatment. Representative samples were then selected 
from the collection of samples based on t-test significance using daily bacterial culture 
plate count and undergo further metabolomics analysis. The metabolomics study was 
performed to detect the changes in metabolites content between the pre-black raspberry 
treatment phase, black raspberry (BRB) treatment phase and post-black raspberry treatment 
(washout) phase.  
 
Distinct Metabolic Profiles of Polar Metabolites Can Be Detected in Response to BRB 
Intervention in Different Section of the Colon  
Polar metabolites are a group of small, hydrophilic molecules such as amino acids, 
nucleic acids, small organic acids, which are often involved in primary metabolism [24]. 
They are critical in normal growth and are crucial for survival in living organisms such as 
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microbes. In order to find out how polar metabolite production will respond to BRB 
intervention, we did a target polar metabolites analysis and hypothesize that the production 
of polar metabolites increases as more microbes grow with BRB.  
In this study, after filtering and normalizing the data obtained, there were a total of  
245 metabolites included in the analysis. Upon completion of the analysis, all three sections 
of the colon had shown distinct endogenous polar metabolic profiles when comparing the 
pre-treatment phase to the treatment phase. PLSDA plot of ascending colon had shown the 
distinct polar metabolites profile by comparing pre-treatment (in pink) to treatment phase 
(in green) (Figure 2A). For ascending colon, of the ten metabolites that contributed to the 
distinct metabolic profile, myristic acid contributed the most to the distinct metabolite 
profile observed (Figure 2B). Just like ascending colon, distinct polar metabolites profile 
was observed in the transverse colon as shown by PLSDA plot by comparing pre-treatment 
(in pink) to treatment phase (in green) (Figure 2C). For transverse colon, of the ten 
metabolites that contributed to the distinct metabolic profile, (5E,7E)-9,10-Secocholesta-
5,7,10-triene-3,25-diol contributed the most to the distinct metabolite profile observed 
(Figure 2D). A similar trend is observed in descending colon as it also had a unique 
metabolic profile when comparing pre-treatment to treatment phase (Figure 2E). For 
transverse and descending colon, they had shared most of the metabolites that contributed 
to the diverse metabolic profile, such as linoleic acid and 9-hydroperoxy-10E,12Z-




Figure 2: the panel of figures shown the polar metabolite changes in different vessels 
representing ascending colon, transverse colon and descending colon. A, C, E: PLSDA 
plot showing the distinct profile present in specific section of the colon by comparing pre-








metabolites that contributed the most to the distinct metabolic profiles between the two 
phases of the experiment in B: ascending colon, D: transverse colon E: descending colon 
and the list was derived using MetaboAnalyst algorithm using peak area.  
 
 
To compare how different sections of the colon respond to BRB treatment, a 
comparison of HCM vessels was performed to reveal the different metabolite profiles 
during the treatment stage in all three sections of the colon. All three sections of the colon 
had shown distinct changes in the metabolic profile during the treatment phase, which was 
mainly driven by the abundance of 14-hydroxymyristic acid, uridine monophosphate and 
trans-cinnamic acid (Figure 3A-B). It is also worth noting that the trend of metabolite 
relative abundance changes as shown in the heatmap in ascending colon was unique 
compared to the later sections of the colon while transverse and descending colon share a 
similar trend in how metabolic relative abundance changes (Figure 3C). For example, for 
M1 to M7, ascending colon is showing a decreasing trend in the production of these polar 
metabolites while transverse and descending colons were showing an increasing trend in 




Figure 3: localizing comparison of three sections of the colon while black raspberry 
extract was added as the treatment and its impact on endogenous polar metabolic profile 
of microbiome in HCM. A: PSLDA plot of showing the distinct profile present in 
ascending (in pink), transverse (in green) and descending (in blue) colon during the 
treatment phase. B: VIP scores plot of the top 10 metabolites that were contributing to 
the distinct metabolic profiles between the two phases of experiment in HCM. C: 
heatmap showing the trend of top 25 metabolites responded to BRB extract while HCM 





































Significant Changes Can Be Detected in Phenolic Compounds between Treatment 
Versus Wash Out Phases 
Polyphenol is a group of secondary metabolites that are commonly found in fruits, 
vegetables and plant-derived food such as chocolates. It was reported in previous studies 
that polyphenol can regulate microbial composition balance and enhance the growth of 
beneficial metabolites through their metabolites and thus behave like prebiotics [25]. 
Polyphenols can be dived into flavonoids or non- flavonoids and BRB extract contains both 
of these groups [18][26]. In order to understand how polyphenol can correct dysbiosis and 
enhance the production of beneficial compounds, we performed targeted profiling for 
polyphenol and its derivatives in metabolism. We had shortlisted 30 compounds for target 
phenolic compounds analysis. Out of 30 compounds in the Mzvault database, 12 were 
detected in BRB extract only, 5 compounds were detected in ascending colon of HCM. Of 
the 5 compounds, 2 of them, namely protocatechuic acid and hesperetin, had shown a 
significant increase in the peak area detected during the treatment phase and post-treatment 
phase, with t-test p< 0.005 and p<0.001 respectively (Figure 4A). For transverse colon, 
similar in the number of metabolites detected, quercetin and naringenin had shown a 
significance in the relative abundance of metabolites detected. Quercetin had shown a 
significant decrease in peak area during the treatment phase and washout phase, while 
naringenin was significantly increased, treatment phase and washout phase, with t-test p< 
0.001 and p<0.05 respectively (Figure 4C). There is no significant change reported in 
descending colon, which might be due to the dilution effect in the vessels and thus the 




























Figure 4: panel of figures showing phenolic metabolites analysis. A: figure showing 
five metabolites that were detected in ascending colon of HCM. Of the five metabolites, 
protocatechuic acid and hesperetin had shown significance change in the amount of 
metabolites detected during treatment phase and post treatment phase, with t test p< 
0.005 and p<0.001 respectively B: figure showing five metabolites that were detected 
in ascending colon of HCM. Of the five metabolites, quercetin and naringenin had 
shown significance change in the amount of metabolites detected during treatment 
phase and post treatment phase, with t test p< 0.001 and p<0.05 respectively. Figures: 






BRB Extract Can Positively Impact on Production of Short-Chain Fatty Acids in 
Ascending and Transverse Colons   
Short-chain fatty acids (SCFAs) are products of anaerobic fermentation by 
microbes in the large intestine [27]. Microbes, such as Bifidobacteria or Lactobacilli, can 
act on polysaccharides that were not used by humans such as dietary fiber and resistant 
starch [28]. SCFAs can be dived into 2 groups: branched and unbranched and we had 
decided to focus on both of these groups as each will impact human health differently and 
produced by a different group of bacteria. If the amount of probiotics increases, linear 
SCFA increases. In our study, there was 9 total short-chain fatty acid included for target 
profiling (acetic acid, propionic acid, isobutyric acid, butyric acid, 2-methylbutyric acid, 
isovaleric acid, valeric acid, isocaprioic acid and hexanoic acid). In ascending colon, all 9 
SCFAs were detected but 6 of them were detected at higher abundance. We were unable 
to quantify the amount of acetic acid present in the ascending colon as its peak area did not 
fit the range of the calibration curve. Statistical analysis using t-test had shown that 
propionic acid, isobutyric acid, 2-methylbutyric acid and hexanoic acid, had shown a 
significant increase in the concentration between pre-treatment to treatment phase in 
ascending colon (t-test p <0.05) (Figure 5A). Valeric acid had also shown a significant 
increase in the concentration between pre-treatment to treatment phase in ascending colon 
(t-test p <0.05). Isovaleric acid had shown a significant increase in the concentration 
between pre-treatment to wash out phase with t-test p <0.01 (Figure 5A). With regards to 
the transverse colon, 7 metabolites had been detected and 2 of them, namely propanoic acid 
and isovaleric acid, had shown a significant increase between pre-treatment to wash out 
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phase (t-test p< 0.05) (Figure 5B). There were no significant changes detected in the 




Figure 5:  A: figure showing short chain fatty acid relative abundance in ascending 
colon, 6 out of 9 metabolites had shown significant changes between the three phases 
of experiments. Statistical analysis shown that propionic acid, isobutyric acid, 2-
methylbutyric acid and hexanoic acid shown a significant increase in concentration 
between pre-treatment to treatment phase in ascending colon (t-test p <0.05). Isovaleric 
acid and valeric acid also shown a significant increase in their concentration (t-test p 
<0.01). there are no significant changes detected in other sections of the colon. B: figure 
showing short chain fatty acid relative abundance in transverse colon, 2 out of 9 
metabolites had shown significant changes between the three phases of experiments. 
Statistical analysis shown that propionic acid, isovaleric acid shown a significant 
increase in concentration between pre-treatment to treatment phase in ascending colon 
(t-test p <0.05). There is no significant changes detected in descending colon and thus 





 The original intent of this thesis study was aimed to uncover how a representative 
dietary component, black raspberry (BRB), can influence human gut microbial 
composition and metabolism, so we can understand its gut microbiota-mediated health 
effects on humans. However, due to pandemic impact, metagenomic processing is still 
ongoing and thus, we now focus on how BRB can impact the microbial metabolism and 
the production of its associated metabolites (polar, phenolic and short-chain fatty acids), 
and try to establish a foundation for the study of their future impact to human health. We 
hypothesize the dietary intervention of BRB will remodel gut microbial metabolism and 
alter the production of potentially beneficial metabolites. In order to establish the link on 
how BRB could remodel microbial metabolism, I had utilized an innovative HCM model 
to mimic the human intestine environment without host interaction to study explicitly the 
BRB-gut microbiota interactions. The HCM was run for 6 weeks to allow the observation 
of longitudinal changes in microbiota and their metabolites, univariate and multivariate 
data analysis approaches were also applied to draw scientific conclusions.  
 
Potential Physiological Benefits of Our Detected Microbial Polar Metabolites and their 
Roles in Cancer Prevention/Treatment 
From the polar metabolites results, we can see that BRB extract is capable of 
inducing metabolic changes in all three sections of the colon for endogenous polar 
metabolites produced by gut microbes, with stronger similarity in the metabolic changes 
between transverse and descending colons. Polar metabolites are a group of small, 
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hydrophilic metabolites such as amino acids, nucleic acids, sugars and other organic acids 
that plays a vital role in normal growth and development in living organisms, as they are 
typically part of the primary metabolism [24]. Changes in endogenous polar metabolites 
thus signify there are changes in microbial growth and potentially microbial diversity. In 
this experiment, both 9-HpODE and linoleic acid were increased in the transverse and 
descending colons. 9-HpODE is formed from the non-enzymatic oxidation of linoleic acid 
[29]. It is reported that in a cohort study, where comparison was made on the serum 
metabolites between healthy volunteer and colorectal cancer patient, they found that 
linoleic acid can serve as a biomarker for colorectal cancer as its relative abundance is 
much lower in colorectal cancer patient as compared to healthy volunteer [30]. In a mouse 
study on the intestinal tumor, researchers also found that linoleic acid, a long-chain fatty 
acid, has an anti-tumor effect on specific cell lines of cancer such as KPL-1 and BT-474 in 
breast cancer, Caco-2 in colorectal cancer, A549 in lung cancer and DU145 in prostate 
cancer [31]. Briefly, an increased intake of n-3 polyunsaturated fatty acids from food, such 
as linoleic acid, was able to reduce the risk for breast cancer development [32][33]. Such a 
result was confirmed as in a reported animal study that prostaglandin E (PGE) production 
decreases when female BALB/c mice were fed with linseed oil, decreasing PGE reduces 
the growth of tumor [34]. Since BRB extract can upregulate the production of linoleic acid, 
BRB dietary intervention might have a similar effect on other cancer patients as PGE is 
found universally in many cancers, including lung cancer and its concentration is directly 
proportional to the growth rate of lung cancer [35].  
It was reported in a literature review that different locations may have different 
microbial populations thus, contribute to different colon cancer incidence [36]. After 
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comparing three sections of the colon via location analysis, I discovered that ascending 
colon has a unique trend while the transverse colon and descending shared a similar trend 
in endogenous polar metabolites production. As BRB treatment feeding medium first enter 
the ascending colon (Vessel 1), the microbes were exposed to 5ml/L of BRB extract. 
However, the concentration of fresh BRB extract will become much lower in the transverse 
and descending colon as the media were first utilized by microbes in ascending colon and 
was diluted by a great extent when passed on to following colon compartments. As such, 
the remaining BRB extract exposed to transverse and descending colons might not meet 
the concentration thresholds to create a similar change to ascending colon. Therefore, I 
hypothesis that transverse and descending colon will have a similar metabolic profile as 
they are exposed to a similar concentration of BRB extract while ascending colon received 
fresh media. Location analysis also provided insights into the important metabolites that 
contributed to the distinct metabolic profile. In my experiment, the uniqueness of metabolic 
profile in a different section of the colon was contributed by the differences in 
concentration present in 14-hydroxymyristic acid, uridine monophosphate and trans-
cinnamic acid across all sections of the colon. Of the three metabolites, trans-cinnamic acid 
is able to induce cancer cell death by the inhibition of histone deacetylases in athymic mice 
of colon cancer [37]. Similar findings had also been reported for cervical cancer via the 
same mechanism [38]. With all these information, I hypothesis that an increase in trans-
cinnamic acid could curb the proliferation in other cancer patients too.  
Potential Physiological Benefits of Detected Phenolic Compounds from the Gut 
Environment  
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 Phenolic compounds are a group of bioactive ingredient that has antioxidant and 
cytotoxic activities [16]. Like many other berries, such as strawberry and pomegranate,  
black raspberry contains a rich source of anthocyanins and poorly absorbed ellagitannins 
[16]. In this study, we had observed that 2 out of 5 phenolics detected have statistical 
significance in selected sections of the colon, namely protocatechuic acid and hesperetin 
for ascending colon and quercetin and naringenin in the transverse colon. Protocatechuic 
acid, hesperetin and quercetin had decreased drastically when BRB extract was removed 
during the washout phase, indicates that the decrease was from withdrawing effects. Such 
observation is consistent with a previous study done for quercetin in a mice model using 
lychee pulp [39]. However, naringenin increased after BRB extract was removed, 
suggesting there might be microbes that are capable of producing such phenolic 
compounds from other phenolic components in BRB. As reported by Chen et al, both 
naringenin and 3-(4′-hydroxyphenyl) propanoic acid (HPPA) are products of naringin [40]. 
Therefore, the increase in naringenin might be attributed to the increase in naringin present 
in the HCM and naringin is derived from rutin [41]. As there is a slight increase in rutin in 
ascending colon, the excess might be transferred over to the transverse colon and resulted 
in such a significant increase. There is no statistical significance observed for polyphenols 
in descending colon as the BRB media might be too diluted after passing through the 
ascending and transverse section of the colon.  
Existing literature has discussed the biological function of polyphenols in humans. 
For example, protocatechuic acid was known to have antibacterial, anticancer and anti-
inflammatory activities [11]. It was reported by Suzuki et al that using the male F344 rats 
model, protocatechuic acid exhibited chemo-preventative activity as it can decrease the 
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likelihood of precancerous lesions and metastasizing to the lungs [42]. Chemo-preventative 
effects were also seen in hesperetin, quercetin and naringenin in vitro studies for breast 
cancer (MDA-MB-435 and HER2) [43][44]. Specifically, in HER2-positive cancer, 
hesperetin and naringenin can promote cancer cell death by functioning as a HER2 tyrosine 
kinase inhibitor [44]. Taken together, our limited results of phenolic compounds may 
suggest their involvement in cancer prevention, development and treatment in certain 
tumors. However, more mechanistic studies have to be performed down the road using 
these phenolic compounds to truly allow the discovery of their biological functions in 
modulating gut microbial metabolism and consequentially impact human health. 
 
Potential Physiological Functions of Short-Chain Fatty Acids  
 Short-chain fatty acids (SCFAs) are defined as any fatty acids less than six carbons, 
most of them were the product of anaerobic fermentation of fibers from the diet, while the 
rest were produced from the lactate pathway [45]. In this study, we had included nine 
SCFAs in our analysis, namely acetic acid, propionic acid, isobutyric acid, butyric acid, 
isovaleric acid, valeric acid, isocaproic acid and hexanoic acid. Most of which are straight-
chain fatty acids, except for isobutyric acid, isovaleric acid and isocaproic acid. It was 
reported in many publications that an increase in many SCFAs has health benefits, 
including but not limited to anti-cancer effects, decreasing the production of 
proinflammatory cytokines, alter gut integrity and weight loss [46][47][48]. There are 
SCFAs detrimental health impacts as well, where high levels of branched SCFAs in the 
fecal sample correlate with obesity, a risk factor for many chronic diseases [49]. 
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 In our study, we had observed that 6 out of 9 SCFAs (propionic acid, isobutyric 
acid, 2-methylbutyric acid and hexanoic acid, isovaleric acid and valeric acid) were 
statistically significant between the pre-treatment and treatment phase in ascending colon. 
The changes of our detected propionic acid and valeric acid are consistent with a mice 
study done by Huang et al using lychee pulp [50].   It was reported that propionate and 
butyrate were important metabolites to maintain gut homeostasis, where people with active 
inflammatory bowel disease (IBD) contain less of these SCFAs in their fecal sample as 
compared to healthy adults, and IBD is an indication of dysbiosis [51]. It was also reported 
that prebiotics can improve such dysbiosis [25]. As the SCFA concentration increases in 
our study after BRB extract was added, this might be an indication that polyphenol in BRB 
can improve the microbial metabolic profile.   
 Many researchers also looked into the anti-cancer effects of SCFAs using in vitro 
studies or mice models [52]. Butyric acid was well studied in its mechanism in cancer 
prevention and treatment. Kuefer et al did an in vitro study on prostate cancer and found 
that sodium butyrate would acetylate p53 that induces p21, which then inhibits the activity 
of cyclin-dependent kinase 2. The result of such cellular action is cell cycle is arrested in 
the G1 phase of the cell cycle [53]. Work done by Terui’s group further shows that p53 
activation upregulates PIG3 and NOXA associated pathways, leading to cell death [54]. 
Another aspect of anti-cancer effects of butyrate is to activate the death receptor pathway 
components, which was demonstrated in the work done by Hernandez et al and Kim et al. 
In vitro study had shown that sodium butyrate increases the sensitivity of tumor necrosis 
factor-related apoptosis-inducing ligand (TRAIL) resistant colon cells to undergo 
apoptosis [55]. Also demonstrated using colon cancer cells, sodium butyrate can upregulate 
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expression of DR5, a membrane of TRAIL, so to initiate cell apoptosis [56]. In our study, 
butyric acid increases between pre-treatment and washout phases in the transverse colon. 
This means that patients who have higher risk of developing lung cancer can benefit from 
the production of SCFAs in the host gut and thus, escalate host-mediated anti-tumor 
responses to curb the progression of cancer.  
There were also studies done on the association of bacteria phylum on the 
production of SCFA metabolites. For example, a report by Derrien et al. suggested that 
probiotics like Akkermansia muciniphila are a major propionate producer [57]. Bacteria 
phyla like Bacteroidetes, also produce propionate, while butyrate was mainly produced by 
Firmicutes [45]. Both phyla are part of the commensal bacteria in the gut and account for 
in total 90% of the gut microbiota in humans [58]. Since there was an increase in the 
production of propionic acid in our study, we can extrapolate that such an increase in 
SCFAs might be due to an increase in certain probiotics after the addition of BRB. Such a 
hypothesis will be further confirmed by the result from metagenomic analysis in the future.  








In summary, we explored the association between BRB intervention and gut 
microbial metabolism in this study, and discussed its potential health implication on the 
cancer patient. Our results show that BRB extract is capable of modulating microbiome 
metabolism as important groups of metabolites, namely polar, phenolic and short-chain 
fatty acids, had shown significant changes among pre-treatment, treatment and washout 
phases. Our data may be used to explain how BRB extract can function as prebiotics and 
promote the growth of probiotics, thus enhance the production of functioning metabolites 
that played a positive role in host physiological health. The increased production of 
beneficial metabolites, such as linear short-chain fatty acids, by gut microbes, can 
potentially curb tumor proliferation in cancer patients by downregulating the production of 
prostaglandin E, which is an important cancer growth factor that promotes cancer 
proliferation [59].  
Although we speculate the increase in SCFAs may be due to the changes in the 
population of certain SCFA-producing bacteria, due to the incomplete process of 
metagenomics data collection impacted by COVID, we were unable to establish the link 
between microbial population and its metabolites production precisely so that we can 
pinpoint the significant change in polar and phenolic compounds to a specific species of 
bacteria. To complete the puzzle, what we would like to do next is to continue with the 
metagenomic study of our samples. Once the result from 16s rRNA and transcriptomics 
were out, as done previously in our lab, the Kyoto Encyclopaedia of Genes and Genomes 
database coupled with Statistical Analysis of Metagenomics profiles (STAMP) will be used 
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to analyze functional data  [21]. This is to relate the changes in metabolomics study to 
microbial population and provide insight on how BRB extract might be able to correct 
dysbiosis and improve beneficial metabolites production through promoting the growth of 
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Supplementary table  
Code  Full name/code of metabolites  
M1 Pyridoxial 
M2 GPK 
M3 Uridine monophosphate 
M4 14-hydroxymyristic acid 
M5 Lauric acid anion 




M10 5-Aminovaleric acid 
M11 L-Proline 
M12 D-Proline 








M21 Trans-3-Indoleacrylic acid 
M22 Glycocholic acid H 
M23 Glycocholic acid 
M24 Leucine 
M25 5Z,8Z,11Z,14Z-5,8,11,14-Tetraenoic acid 
 
